Dai Wu-Xing, Chen Zhi-Hao, Gao Hong, Huang Hai-Lang, Liang Liang, Cheng Ji-Zhong, Huangfu Yong-Mu
Department of Biochemistry and Molecular Biology of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China.
Sheng Wu Gong Cheng Xue Bao. 2004 Mar;20(2):170-4.
To construct the secretive prokaryotic shuttle expression plasmid pBCG-SP-HSP65, the signal peptide sequence of antigen 85B amplified from Bacillus Calmette-guérin (BCG) genome by PCR and the whole HSP65 DNA sequence of human M. tuberculosis obtained from the plasmid pCMV-MTHSP65 by PCR were cloned into the plasmid pBCG-2100 under the control of the promoter of Heat Shock Protein 70 (HSP70) from human M. tuberculosis. Recombinants were electroporated into Mycobacterial smegmatis and induced by heating. Results of the induced expression were detected by SDS-PAGE and the biological activity of the expressed protein was tested by Western-blot analysis. Results showed pBCG-SP-MTHSP65 was constructed successfully and confirmed by restriction endonuclease analysis, PCR detection and DNA sequencing analysis. After it was electroporated into Mycobacterial smegmatis and induced by heating, the percentage of expressed 65kD protein in Mycobacterial smegmatis detected by SDS-PAGE was 20% in total bacterial protein. But the percentage of expressed 65kD protein in recombibinant Mycobacterial smegmatis was up to 34.46% in total bacterial protein and 68.56% in the total protein of cell lysate supernants, Which demonstrated the recombinant HSP65 gene could express in recombinant with high efficiency and the expressed proteins were mainly soluble. Western-blot showed that the secretive proteins could specially combine with antibody against human M. tuberculosis HSP65. Orally, pBCG-SP-HSP65 was successfully constructed; HSP65 gene could express in Mycobacterial smegmatis with high efficiency via it. And the expressed proteins possess the biological activity. So it provids experimental evidence for the application of the recombinant Mycobacterial smegmatis and the development of the vaccine against tuberculosis.
为构建分泌型原核穿梭表达质粒pBCG-SP-HSP65,通过PCR从卡介苗(BCG)基因组中扩增出抗原85B的信号肽序列,并通过PCR从质粒pCMV-MTHSP65中获取人结核分枝杆菌的完整HSP65 DNA序列,将其克隆到受人类结核分枝杆菌热休克蛋白70(HSP70)启动子控制的质粒pBCG-2100中。将重组体电穿孔导入耻垢分枝杆菌并进行加热诱导。通过SDS-PAGE检测诱导表达结果,并用Western印迹分析检测表达蛋白的生物学活性。结果表明,pBCG-SP-MTHSP65构建成功,并经限制性内切酶分析、PCR检测和DNA测序分析证实。将其电穿孔导入耻垢分枝杆菌并加热诱导后,SDS-PAGE检测显示耻垢分枝杆菌中表达的65kD蛋白占总细菌蛋白的20%。但在重组耻垢分枝杆菌中,表达的65kD蛋白占总细菌蛋白的34.46%,占细胞裂解物上清总蛋白的68.56%,这表明重组HSP65基因能高效表达,且表达的蛋白主要为可溶性。Western印迹显示,分泌蛋白能与抗人类结核分枝杆菌HSP65抗体特异性结合。口服给药时,pBCG-SP-HSP65构建成功;HSP65基因可通过它在耻垢分枝杆菌中高效表达。且表达的蛋白具有生物学活性。因此,为重组耻垢分枝杆菌的应用及抗结核疫苗的研发提供了实验依据。